News

Bristol-Myers Squibb Company announced that the European Commission (EC) has approved Empliciti (elotuzumab) plus pomalidomide and low-dose dexamethasone (EPd) for the treatment of…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to delay the progression of renal…
Read More...

The U.S. Food and Drug Administration approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD)…
Read More...

The WIRB-Copernicus Group's (WCG) Clinical Services Division introduces Velos eResearch eXpress, an out-of-the-box, cloud-based solution that enables clinical research sites to…
Read More...

Mustang Bio, Inc. announced that it has entered into a license agreement with CSL Behring for the Cytegrity stable producer cell line developed and used by St. Jude Children’s Research…
Read More...

ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and Freenome, a biotechnology company that…
Read More...

Johnson & Johnson and its Janssen Pharmaceutical Companies announced they will appeal the $572 million civil judgment entered in Cleveland County District Court in the State of…
Read More...

Zogenix, Inc. announced that it has entered into a definitive agreement to acquire Modis Therapeutics, Inc., a privately held biopharmaceutical company focused on developing novel…
Read More...

GlaxoSmithKline plc announced the submission of a Japanese New Drug Application (JNDA) to the Ministry of Health, Labour and Welfare seeking marketing approval for daprodustat, an oral…
Read More...

AstraZeneca announced that it has agreed to buy a US Food and Drug Administration (FDA) Priority Review Voucher (PRV) for a total cash consideration of $95m from a subsidiary of Swedish…
Read More...

AstraZeneca announced that its partner FibroGen (China) Medical Technology Development Co., Ltd. (FibroGen China) has received marketing authorisation for roxadustat in China for the…
Read More...

Iconic Therapeutics, a private biopharmaceutical company focused on novel therapeutics for serious diseases such as cancer and age-related macular degeneration (AMD), announced that the…
Read More...

Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO Impulse System for treatment of STEMI…
Read More...

Enteris BioPharma announced its entry into a definitive licensing agreement with Cara Therapeutics (Nasdaq: CARA) for Enteris' Peptelligence technology in the ongoing development of an…
Read More...

TOKYO & Astellas Pharma Inc. and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the filing of a supplemental New Drug Application…
Read More...

Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. This facility…
Read More...

Innovent Biologics, Inc. (Innovent) announced that it has entered into a licensing agreement with Eli Lilly and Company (Lilly) for the development and potential commercialization of…
Read More...

Enable Injections, Inc. (Enable), a company developing and manufacturing investigational wearable infusion devices for combination products, announced it has entered into a development…
Read More...

Alligator Bioscience announces that a license agreement has been reached with Biotheus Inc. ("Biotheus"), a privately held Chinese company based in Zhuhai, Guangdong, China. Under the…
Read More...

Emendo Biotherapeutics announced that the company achieved the first milestone as laid out in the agreements with Takeda Pharmaceutical Company Limited (Takeda), resulting in the…
Read More...